Position in BIOA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,920,726
+$1,920,726 QoQ
Shares Held
78,365
Ownership
0.171%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#55
of 151 holders
Holding Since
Sep 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIOA Over Time
Shares Held
Position Value (USD)
Derivatives in BIOA
reported options exposure · as of Jun 30, 2026CallValue
$681,378
CallShares
27,800
PutValue
$794,124
PutShares
32,400
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CITADEL ADVISORS LLC holds $1,255,121,114 across 64 Drug Manufacturers - Specialty & Generic names. BIOA ranks #35 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
9,668,611 | $237,944,516 | |
| 2 | ZTS |
Zoetis Inc.
|
3,188,263 | $229,108,578 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
304,692 | $165,091,266 | |
| 4 | LNTH |
Lantheus Holdings, Inc.
|
1,376,480 | $152,706,691 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
2,667,827 | $109,460,941 | |
| 6 | ALKS |
Alkermes plc.
|
1,645,101 | $86,203,291 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
1,373,982 | $63,903,902 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
846,936 | $29,363,271 |
All Filings in BIOA
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $681,378 | 27,800 | Call | Defined | 2026-08-14 | |
| 2026-06-30 | $794,124 | 32,400 | Put | Defined | 2026-08-14 | |
| 2026-06-30 | $1,920,726 | 78,365 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $300,828 | 17,200 | Put | Defined | 2026-05-15 | |
| 2025-12-31 | $3,050,083 | 230,543 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $670,690 | 114,063 | Shares | Defined | 2025-11-14 | |
| 2025-09-30 | $65,268 | 11,100 | Call | Defined | 2025-11-14 | |
| 2025-09-30 | $137,004 | 23,300 | Put | Defined | 2025-11-14 | |
| 2025-06-30 | $452,668 | 109,605 | Shares | Defined | 2025-08-14 | |
| 2025-06-30 | $100,359 | 24,300 | Put | Defined | 2025-08-14 | |
| 2024-09-30 | $4,445,334 | 213,718 | Shares | Defined | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||